"ｍＲＮＡ" の関連情報検索結果
News
Q&A
Shopping
Auction
Rakuten
amazonModerna’s mRNA flu vaccine more effective than standard shot in late-stage trial - NBC News
Moderna’s mRNA flu vaccine more effective than standard shot in late-stage trial NBC News
Germany: BioNTech shutting down COVID vaccine production - DW.com
Germany: BioNTech shutting down COVID vaccine production DW.com
Structural basis for recognition of diverse localizing mRNAs by Egl–BicD - Nature
Structural basis for recognition of diverse localizing mRNAs by Egl–BicD Nature
ParcelBio Launches with $13 Million in Financing to Advance Next-Generation mRNA Medicines - Busi...
ParcelBio Launches with $13 Million in Financing to Advance Next-Generation mRNA Medicines Business Wire
Moderna Announces New England Journal of Medicine Publication of Pivotal Phase 3 Clinical Safety ...
Moderna's mRNA flu vaccine outperforms standard shot in late-stage trial - Reuters
Moderna's mRNA flu vaccine outperforms standard shot in late-stage trial Reuters
Vertex drops Moderna-partnered inhaled cystic fibrosis candidate after unresolved tolerability is...
Vertex drops Moderna-partnered inhaled cystic fibrosis candidate after unresolved tolerability issues Fierce Biotech
mRNA-1010 superior to standard-dose vaccine for preventing flu, finds study - Medical Xpress
mRNA-1010 superior to standard-dose vaccine for preventing flu, finds study Medical Xpress
Exclusive: Startup aims to lift mRNA out of purgatory with more durable therapies - Endpoints News
Exclusive: Startup aims to lift mRNA out of purgatory with more durable therapies Endpoints News
Trivalent mRNA Flu Shot More Effective Than Standard Vaccines - MedPage Today
Trivalent mRNA Flu Shot More Effective Than Standard Vaccines MedPage Today
Phase 3 trial finds Moderna mRNA flu vaccine outperforms standard vaccine in older adults - CIDRAP
Phase 3 trial finds Moderna mRNA flu vaccine outperforms standard vaccine in older adults CIDRAP
Polymer–mRNA complexes for monocyte-trafficked, lymph node-targeted cancer vaccination - Nature
Polymer–mRNA complexes for monocyte-trafficked, lymph node-targeted cancer vaccination Nature
Did Moderna Start Developing Hantavirus mRNA Vaccine in 2024? What We Know - Newsweek
Did Moderna Start Developing Hantavirus mRNA Vaccine in 2024? What We Know Newsweek
A new design framework for mRNA vaccines could improve efficacy and safety - Drug Discovery News
A new design framework for mRNA vaccines could improve efficacy and safety Drug Discovery News
New OCABR vaccine guidelines to improve regulation efficiency - European Pharmaceutical Review
New OCABR vaccine guidelines to improve regulation efficiency European Pharmaceutical Review
ParcelBio: $13 Million Seed Financing Raised To Advance Next-Generation mRNA Medicines - Pulse 2.0
ParcelBio: $13 Million Seed Financing Raised To Advance Next-Generation mRNA Medicines Pulse 2.0
New Research Challenges Understanding of mRNA Vaccines and Establishes Innovative Way to Make The...
Investors Buy Large Volume of Moderna Call Options (NASDAQ:MRNA) - MarketBeat
Investors Buy Large Volume of Moderna Call Options (NASDAQ:MRNA) MarketBeat
Moderna’s mRNA flu vaccine more effective than current SOC - Yahoo
Moderna’s mRNA flu vaccine more effective than current SOC Yahoo
Korea University and Moderna have been working on mRNA hantavirus vaccine since 2023 - Brussels S...
Korea University and Moderna have been working on mRNA hantavirus vaccine since 2023 Brussels Signal
Moderna stock jumps 10% amid hantavirus outbreak concerns - Investing.com
Moderna stock jumps 10% amid hantavirus outbreak concerns Investing.com
ParcelBio Launches With $13 Million Seed Round to Advance Next-Generation mRNA Therapeutics - cit...
ParcelBio Launches With $13 Million Seed Round to Advance Next-Generation mRNA Therapeutics citybiz
mRNA vaccine immunity is enhanced by hepatocyte detargeting and not dependent on dendritic cell e...
NAT10 maintains stem cell homeostasis by mitigating mRNA decay through an ac - Nature
NAT10 maintains stem cell homeostasis by mitigating mRNA decay through an ac Nature
Tuning the immune response to mRNA vaccines - Nature
Molecular insights into DDX3X–androgen receptor mRNA regulation via non-canonical G-quadruplex in...
Investigational Pancreatic Cancer Vaccine Shows Lasting Results in Early Trial, Supporting Contin...
Investigational Pancreatic Cancer Vaccine Shows Lasting Results in Early Trial, Supporting Continued Testing Memorial Sloan Kettering Cancer Center
mRNA vaccines follow unconventional immune path to destroy tumors - WashU Medicine
mRNA vaccines follow unconventional immune path to destroy tumors WashU Medicine
Translation-dependent degradation of cas12 mRNA triggered by an anti-CRISPR - Nature
Translation-dependent degradation of cas12 mRNA triggered by an anti-CRISPR Nature
Pancreatic cancer mRNA vaccine shows lasting results in an early trial - NBC News
Pancreatic cancer mRNA vaccine shows lasting results in an early trial NBC News
A multiobjective AI model for LNP engineering enhances tissue-selective mRNA delivery - Nature
A multiobjective AI model for LNP engineering enhances tissue-selective mRNA delivery Nature
Programmable mRNA startup ParcelBio raises $13m - Longevity.Technology
Programmable mRNA startup ParcelBio raises $13m Longevity.Technology
Membrane insertion of mitochondrial-encoded proteins regulates ribosome decoding speed - Nature
Membrane insertion of mitochondrial-encoded proteins regulates ribosome decoding speed Nature
mRNA Cancer Vaccine Biologic Lines Market Growth Outlook to 2035: Personalized Therapies and Cold...
mRNA vaccines engage unconventional pathways in CD8+ T cell priming - Nature
mRNA vaccines engage unconventional pathways in CD8+ T cell priming Nature
After a year of turmoil, cancer researchers see promising signs for mRNA vaccines - CNN
After a year of turmoil, cancer researchers see promising signs for mRNA vaccines CNN
Moderna stock holds steady amid regulatory review of mRNA-1010 in US, EU, Canada, Australia - Tra...
Moderna stock holds steady amid regulatory review of mRNA-1010 in US, EU, Canada, Australia Traders Union
Cracking the (zip)code of dynein-dependent RNA localization - Nature
Cracking the (zip)code of dynein-dependent RNA localization Nature
BioNTech made €19B in 2021. This quarter: €118M. Now it's cutting 1,860 jobs and betting €16.8B i...
BioNTech made €19B in 2021. This quarter: €118M. Now it's cutting 1,860 jobs and betting €16.8B in cash on returning to its oncology roots. drugdiscoverytrends.com
Has The Market Rerated Moderna (MRNA) Too Quickly After Its Recent Share Price Surge? - simplywal...
Has The Market Rerated Moderna (MRNA) Too Quickly After Its Recent Share Price Surge? simplywall.st
UK Leads Global Bird Flu Vaccine Trial - Medscape
Moderna (MRNA) Is Down 10.6% After Q1 Loss Widened On Settlement And EU Vaccine Wins – Has The Bu...
Moderna (MRNA) Is Down 10.6% After Q1 Loss Widened On Settlement And EU Vaccine Wins – Has The Bull Case Changed? Yahoo Finance
MRNA Q1 Deep Dive: International Partnerships and Pipeline Progress Offset Litigation Headwinds -...
MRNA Q1 Deep Dive: International Partnerships and Pipeline Progress Offset Litigation Headwinds Yahoo Finance
Vertex Files Casgevy sBLA for Younger Patients, Stops Developing Inhaled mRNA Cystic Fibrosis Dru...
Vertex Files Casgevy sBLA for Younger Patients, Stops Developing Inhaled mRNA Cystic Fibrosis Drug Precision Medicine Online
Assessing Moderna (MRNA) Valuation After Strong Q1 Results And New EU Vaccine And Oncology Milest...
Assessing Moderna (MRNA) Valuation After Strong Q1 Results And New EU Vaccine And Oncology Milestones simplywall.st
Moderna's flu shot heads to FDA decision after NEJM Phase 3 data - Stock Titan
Moderna's flu shot heads to FDA decision after NEJM Phase 3 data Stock Titan
ParcelBio Launches with $13 Million in Financing to Advance Next-Generation mRNA Medicines - Eagl...
ParcelBio Launches with $13 Million in Financing to Advance Next-Generation mRNA Medicines Eagle-Tribune
Next-Generation mRNA Capping Technologies Market Business Intelligence and Forecast Report 2026 t...
A retreat from mRNA research could have lasting costs - marketplace.org
A retreat from mRNA research could have lasting costs marketplace.org
Moderna expands support for early career Australian mRNA researchers - Biotech Dispatch
Moderna expands support for early career Australian mRNA researchers Biotech Dispatch
Moderna (MRNA) Receives a Buy from Piper Sandler - The Globe and Mail
Moderna (MRNA) Receives a Buy from Piper Sandler The Globe and Mail
A Look At Moderna (MRNA) Valuation After Q1 2026 Earnings And New Vaccine Approvals - Yahoo Finance
A Look At Moderna (MRNA) Valuation After Q1 2026 Earnings And New Vaccine Approvals Yahoo Finance
Sigma Planning Corp Makes New $907,000 Investment in Moderna, Inc. $MRNA - MarketBeat
Sigma Planning Corp Makes New $907,000 Investment in Moderna, Inc. $MRNA MarketBeat
Moderna (MRNA) director converts 4,058 RSUs into common stock - Stock Titan
Moderna (MRNA) director converts 4,058 RSUs into common stock Stock Titan
BioNTech moves to close multiple manufacturing plants, affecting 1,860 jobs - BioSpace
BioNTech moves to close multiple manufacturing plants, affecting 1,860 jobs BioSpace
Moderna (MRNA) Loss Of US$2.8b Keeps Bearish Narratives In Focus - simplywall.st
Moderna (MRNA) Loss Of US$2.8b Keeps Bearish Narratives In Focus simplywall.st
Moderna’s mRNA-1010 Influenza Vaccine Phase 3 Trial Data Published in New England Journal of Medi...
Moderna’s mRNA-1010 Influenza Vaccine Phase 3 Trial Data Published in New England Journal of Medicine geneonline.com
Expanding global access to mRNA vaccines - Nature
Abbas Hussain Sells 5,682 Shares of Moderna (NASDAQ:MRNA) Stock - MarketBeat
Abbas Hussain Sells 5,682 Shares of Moderna (NASDAQ:MRNA) Stock MarketBeat
'Blood clots surge like never before…': McCullough exposes mRNA COVID vaccine lies at Senate hear...
'Blood clots surge like never before…': McCullough exposes mRNA COVID vaccine lies at Senate hearing The Economic Times
Moderna (MRNA) Reports Q1 Loss, Beats Revenue Estimates - Yahoo Finance
Moderna (MRNA) Reports Q1 Loss, Beats Revenue Estimates Yahoo Finance
European regulators recommend approval of combined mRNA vaccine for flu and COVID - CIDRAP
European regulators recommend approval of combined mRNA vaccine for flu and COVID CIDRAP
LNP versatility: From scarless wound healing to treating pancreatic cancer - BioXconomy
LNP versatility: From scarless wound healing to treating pancreatic cancer BioXconomy
Personalized mRNA vaccine induces strong, durable immunity in hard-to-treat breast cancer - Nature
Personalized mRNA vaccine induces strong, durable immunity in hard-to-treat breast cancer Nature
Why you should keep getting mRNA vaccines - Scientific American
Why you should keep getting mRNA vaccines Scientific American
Moderna shares rise as investors revisit Q1 results, pipeline milestones, and fresh price-target ...
Moderna shares rise as investors revisit Q1 results, pipeline milestones, and fresh price-target bumps Quiver Quantitative
MRNA Q1 Deep Dive: International Partnerships and Pipeline Progress Offset Litigation Headwinds -...
MRNA Q1 Deep Dive: International Partnerships and Pipeline Progress Offset Litigation Headwinds StockStory
Legal settlement drives Q1 2026 loss at Moderna (NASDAQ: MRNA) - Stock Titan
Legal settlement drives Q1 2026 loss at Moderna (NASDAQ: MRNA) Stock Titan
Hope for pancreatic cancer? Top oncologists explain how an experimental vaccine hunts down rogue ...
Hope for pancreatic cancer? Top oncologists explain how an experimental vaccine hunts down rogue cells The Indian Express
Moderna Announces New England Journal of Medicine Publication of Pivotal Phase 3 Clinical Safety ...
NFID Statement on mRNA Technology - National Foundation for Infectious Diseases
NFID Statement on mRNA Technology National Foundation for Infectious Diseases
Moderna stock jumps after Q1 2026 beat (MRNA:NASDAQ) - Seeking Alpha
Moderna stock jumps after Q1 2026 beat (MRNA:NASDAQ) Seeking Alpha
Individualized mRNA vaccines evoke durable T cell immunity in adjuvant TNBC - Nature
Individualized mRNA vaccines evoke durable T cell immunity in adjuvant TNBC Nature
Non-covid mRNA Vaccine and Therapeutics Market Supply Chain Analysis and Revenue Forecast 2026 to...
Moderna says FDA will now consider its new mRNA flu shot after initial refusal - PBS
Moderna says FDA will now consider its new mRNA flu shot after initial refusal PBS
Pfizer vs Moderna: Only One Pharma Giant Is a Winner In The Post-Covid Era - 24/7 Wall St.
Pfizer vs Moderna: Only One Pharma Giant Is a Winner In The Post-Covid Era 24/7 Wall St.
Cancer vaccines could transform treatment and prevention – but misinformation about mRNA vaccines...
Cancer vaccines could transform treatment and prevention – but misinformation about mRNA vaccines threatens their potential The Conversation
Moderna (NASDAQ:MRNA) Beats Expectations in Strong Q1 CY2026, Stock Soars - The Globe and Mail
Moderna (NASDAQ:MRNA) Beats Expectations in Strong Q1 CY2026, Stock Soars The Globe and Mail
Moderna (MRNA) Reports Earnings Tomorrow: What To Expect - Yahoo Finance
Moderna (MRNA) Reports Earnings Tomorrow: What To Expect Yahoo Finance
Why mRNA is important for U.S. national security - Hopkins Bloomberg Center
Why mRNA is important for U.S. national security Hopkins Bloomberg Center
Moderna, Inc. 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:MRNA) 2026-05-01 - Seeking A...
Moderna, Inc. 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:MRNA) 2026-05-01 Seeking Alpha
mRNA Sequencing Market Gaining Momentum with Rising Genomics Research & Precision Medicine Adopti...
mRNA Sequencing Market Gaining Momentum with Rising Genomics Research & Precision Medicine Adoption openPR.com
Association of mRNA COVID-19 vaccination with overall survival in patients receiving immune check...
Media Coverage of Study Finding COVID-19 mRNA Vaccine Sparks Immune Response to Fight Cancer - UF...
Media Coverage of Study Finding COVID-19 mRNA Vaccine Sparks Immune Response to Fight Cancer UF Health
U.S. rejection of new mRNA flu vaccine 'sends chills,' epidemiologist says - PBS
U.S. rejection of new mRNA flu vaccine 'sends chills,' epidemiologist says PBS
Global landscape of mRNA vaccine clinical trials: a systematic analysis of ClinicalTrials.gov dat...
Global landscape of mRNA vaccine clinical trials: a systematic analysis of ClinicalTrials.gov data Frontiers
EU clears Moderna's flu-COVID shot as Q1 loss hits $1.3B - Stock Titan
EU clears Moderna's flu-COVID shot as Q1 loss hits $1.3B Stock Titan
A New Flu Shot May Boost Protection for Older Adults - AARP
Why Is Moderna Stock Falling Friday? - Moderna (NASDAQ:MRNA) - Benzinga
Why Is Moderna Stock Falling Friday? - Moderna (NASDAQ:MRNA) Benzinga
Breaking barriers in prostate cancer: the mRNA vaccine breakthrough and what comes next - Nature
Breaking barriers in prostate cancer: the mRNA vaccine breakthrough and what comes next Nature
US vaccine panel retreats from mRNA Covid review ahead of midterms | Trump administration - The G...
US vaccine panel retreats from mRNA Covid review ahead of midterms | Trump administration The Guardian
Moderna (NASDAQ: MRNA) grows Q1 2026 revenue but books $1.3B loss - Stock Titan
Moderna (NASDAQ: MRNA) grows Q1 2026 revenue but books $1.3B loss Stock Titan
Moderna (MRNA) Reports Strong Q1 2026 Performance with $400 Million Revenue - GuruFocus
Moderna (MRNA) Reports Strong Q1 2026 Performance with $400 Million Revenue GuruFocus
FDA reverses course on Moderna flu shot - NPR
MRNA Stock Rises Pre-Market: Moderna Bets On US Comeback With Flu Vaccine Pipeline - Stocktwits
MRNA Stock Rises Pre-Market: Moderna Bets On US Comeback With Flu Vaccine Pipeline Stocktwits
New report sounds alarm on health fallout from mRNA vaccine funding cuts - Yale School of Public ...
New report sounds alarm on health fallout from mRNA vaccine funding cuts Yale School of Public Health
Moderna (MRNA) Q1 2026 Earnings Transcript - The Globe and Mail
Moderna (MRNA) Q1 2026 Earnings Transcript The Globe and Mail
Igniting Immunity: Elias Sayour’s Patients Inspire Pioneering mRNA Cancer Vaccine Research - UF H...
Igniting Immunity: Elias Sayour’s Patients Inspire Pioneering mRNA Cancer Vaccine Research UF Health
Comparative study of analytical methods for assessing mRNA integrity and identification of functi...
Purdue mRNA therapy delivery system proves to be shelf-stable, storable - Purdue University
Purdue mRNA therapy delivery system proves to be shelf-stable, storable Purdue University